42Stockpicking

CLPT

Clearpoint Neuro Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
19,5
91st %ile · 404p
P/Si
5,7
59th %ile · 356p
EV/Salesi
5,9
60th %ile · 356p
Div yieldi

Kursudvikling

Kun 76 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
76
Årsregnskaber
17
Peers
0/0
Valuation
3/6
Fundamentals
8/8
Datovindue
2026-02-09 til 2026-05-28

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,7 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

CLPT vurderet 2026-06-10

Score
33.3%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

42%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

44%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

34%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

56%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

33%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

46%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
-86.506
Net 90d (værdi)
-1.375.454 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
17.6.2026BURNETT JOSEPHCEO and President◆ OPT.60.000150.000 USDsec
17.6.2026BURNETT JOSEPHCEO and President▼ SALG-60.000-1.067.400 USDsec
4.6.2026Richards Timothy T.◆ OPT.5005.000 USDsec
4.6.2026Richards Timothy T.· ANDET-376-5.001 USDsec
1.6.2026Richards Timothy T.▼ SALG-5.415-65.901 USDsec
21.5.2026Klein Matthew B.▼ SALG-16.000-185.440 USDsec
20.5.2026FALLON LYNNETTE C▼ SALG-5.091-56.714 USDsec
19.5.2026Klein Matthew B.◆ OPT.12.417sec
19.5.2026LIAU LINDA M.◆ OPT.12.417sec
19.5.2026JOHNSON B KRISTINE◆ OPT.12.417sec
19.5.2026Richards Timothy T.◆ OPT.12.417sec
19.5.2026FLETCHER R JOHN◆ OPT.12.417sec
19.5.2026FALLON LYNNETTE C◆ OPT.12.417sec
19.5.2026Girin Pascal E R◆ OPT.12.417sec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-0,32-0,27-17.1%-17.1%Miss
2025Q430.1.2026-0,27-0,20-35.0%-35.0%Miss
2025Q330.10.2025-0,21-0,20-5.0%-5.0%Miss
2025Q230.7.2025-0,21-0,20-5.0%-5.0%Miss